公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2013 | A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine | ARISTINE CHENG ; Fung C.-P.; Liu C.-C.; Lin Y.-T.; Tsai H.-Y.; SHAN-CHWEN CHANG ; Chou A.-H.; Chang J.-Y.; Jiang R.-H.; Hsieh Y.-C.; Su I.-J.; Chong P.C.S.; SZU-MIN HSIEH | Vaccine | 70 | 64 | |
2016 | Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012–2013 | Huang S.-H.; YEE-CHUN CHEN ; Chuang Y.-C.; Chiu S.-K.; Fung C.-P.; Lu P.-L.; Wang L.-S.; Wu T.-L.; JANN-TAY WANG | Journal of Microbiology, Immunology and Infection | 29 | 20 | |
2014 | Sheltering effect and indirect pathogenesis of carbapenem-resistant Acinetobacter baumannii in polymicrobial infection | Liao Y.-T.; Kuo S.-C.; Lee Y.-T.; Chen C.-P.; SHU-WEN LIN ; LI-JIUAN SHEN ; Fung C.-P.; Cho W.-L.; Chen T.-L. | Antimicrobial Agents and Chemotherapy | 35 | 34 | |
2018 | Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan | Su C.-F.; Chuang C.; Lin Y.-T.; Chan Y.-J.; Lin J.-C.; Lu P.-L.; Huang C.-T.; JANN-TAY WANG ; Chuang Y.-C.; Siu L.K.; Fung C.-P. | European Journal of Clinical Microbiology and Infectious Diseases | 23 | 21 | |
2013 | Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: First identification of KPC-2 or NDM-1-producing E. coli in Taiwan | Ma L.; Siu L.K.; Lin J.-C.; Wu T.-L.; Fung C.-P.; JANN-TAY WANG ; Lu P.-L.; Chuang Y.-C. | BMC Infectious Diseases | 40 | 38 |